Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Pegylated arginine deiminase

EU orphan designation number: EU/3/05/289   
Active ingredient: Pegylated arginine deiminase
Indication: Treatment of hepatocellular carcinoma
Sponsor: Dr Francesco Izzo
Pascale National Cancer Institute, via M. Semmola, Naples 80131, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/06/2005 Orphan designation EMEA/OD/087/04 (2005)1910 of 20/06/2005